Cart
sales@molnova.com
Sennoside D
CAS No. 37271-17-3
Sennoside D( —— )
Catalog No. M27951 CAS No. 37271-17-3
Sennoside D is an anthraquinone glycoside extracted from leaves and pods of Cassia angustifolia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 275 | In Stock |
|
| 5MG | 180 | In Stock |
|
| 10MG | 266 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSennoside D
-
NoteResearch use only, not for human use.
-
Brief DescriptionSennoside D is an anthraquinone glycoside extracted from leaves and pods of Cassia angustifolia.
-
DescriptionSennoside D is an anthraquinone glycoside extracted from leaves and pods of Cassia angustifolia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorSTING
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number37271-17-3
-
Formula Weight848.76
-
Molecular FormulaC42H40O19
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 50 mg/mL (58.91 mM)
-
SMILESOC[C@H]1O[C@@H](Oc2cccc3[C@@H](C4c5cccc(O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c5c(O)cc(cc45)C(O)=O)c4cc(CO)cc(O)c4C(=O)c23)[C@H](O)[C@@H](O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Corrales L, et al. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Rep. 2015 May 19;11(7):1018-30.
molnova catalog
related products
-
Magainin Spacer Pept...
Magainin Spacer Peptide
-
ProTx III
Potent Nav1.7 blocker (IC50 = 2.5 nM). Also inhibits Nav1.1, Nav1.2, Nav1.3 and Nav1.6 in the nanomolar range. Exhibits no effects on Cav channels or nAChR at 5 μM. Demonstrates analgesic activity in vivo; antagonizes effects of scorpion-venom toxin OD1 at Nav1.7.
-
PGP-4008
PGP-4008 is a selective and potent P-glycoprotein (Pgp) inhibitor that inhibits tumor growth by co-administration with Doxorubicin.
